Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997543

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department takes to (a) support fertility treatment in the NHS and (b) ensure NHS England and Clinical Commissioning Groups deliver fertility treatments in line with NICE guidelines.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	185587
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Clinical commissioning groups (CCGs) should have regard to the National Institute for Health and Care Excellence (NICE) guideline on the assessment and treatment of people with fertility problems when commissioning services for which they are responsible. This includes the recommendation in the guideline that three cycles of in-vitro fertilisation be offered to qualifying couples where the woman is under the age of 40 and one cycle where the woman is between the ages of 40 and 42.</p><p> </p><p>The NICE guideline is evidence based best practice for clinicians but is not mandatory. The availability of National Health Service funded fertility treatment is and always has been a matter for local determination. Decisions on the level of service provision are underpinned by clinical insight and knowledge of local healthcare needs and priorities.</p><p> </p><p>NHS England is currently undertaking a project to develop a benchmark price for NHS in-vitro fertilisation. This will help CCGs improve value for money in their commissioning. The Human Fertilisation and Embryology Authority are finalising some good practice advice for CCGs about the commissioning of fertility services, which should help improve the quality of commissioning decisions.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 06/11/2018 11:11:00 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4056 label Biography information for Nic Dakin

997549

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Housing: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will (a) work with the Secretary of State for Housing, Communities and Local Government and (b) establish a cross-departmental committee on health and buildings.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	185600
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>The Department welcomes the All Party Parliamentary Group’s report, and we know that a high-quality, safe, and suitable home can help people stay independent and healthy for longer, and reduce health and social care costs. The Department works across Government, including with the Ministry of Housing, Communities and Local Government, on many of the issues highlighted in the report.</p><p> </p><p>Both Departments are signatories to the ‘Health through the Home’ Memorandum of Understanding with Public Health England (PHE). A refreshed version, which emphasises the importance of housing in supporting people’s health, was published by PHE in March 2018. It can be found at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/improving-health-and-care-through-the-home-mou" target="_blank">www.gov.uk/government/publications/improving-health-and-care-through-the-home-mou</a></p><p> </p><p>PHE also recognises the importance of indoor environmental quality (indoor air quality, noise, overheating and ventilation) on human health and wellbeing, and the need for a holistic approach. Further information is available in PHE’s resources on homes and health, available at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/collections/housing-for-health" target="_blank">www.gov.uk/government/collections/housing-for-health</a></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 184967 question first answered 06/11/2018 16:22:44 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

997590

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether all GP practices in the (a) Stroud constituency and (b) England have sufficient supplies of the FluMist flu vaccine to vaccinate all vulnerable groups including those eligible through age.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	185480
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Public Health England (PHE) centrally procures flu vaccines for the children’s national flu immunisation programme, these being the nasal spray Fluenz Tetra supplied by AstraZeneca and a quadrivalent inactivated influenza vaccine supplied by Sanofi Pasteur. This programme provides influenza vaccination for children between the ages of two and 17 years of age. If the Fluenz Tetra nasal spray is unsuitable, children are offered the quadrivalent inactivated influenza vaccine as an alternative. Other vulnerable groups are offered alternative vaccines that are more effective in protecting them against influenza.</p><p> </p><p>Sufficient vaccine has been procured to ensure that all eligible children who present at general practices and schools for vaccination can be offered the appropriate vaccine. Stocks are carefully managed by PHE to ensure there is equitable distribution across England, including the Stroud constituency, and sufficient in-date vaccine for patients who present throughout the season.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/11/2018 15:33:22 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

997640

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 October 2018 to Question 173542 on Allergies: Medical Treatments, what support his Department has provided to people affected by the national shortage of EpiPen 0.3mg auto-injectors.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	185550
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Health products Regulatory Agency, and NHS England to improve the situation as quickly as possible. Supplies of EpiPen 0.3mg and the alternative adrenaline auto-injectors are currently available in volumes that are sufficient to meet normal United Kingdom requirements and further deliveries of all three brands of adrenaline autoinjectors are expected in the coming weeks. Comprehensive information and guidance, with input from National Health Service allergy experts has been cascaded to all healthcare professionals, schools, patient groups and frontline NHS services, which provides information about the supply issue, management options and advice to share with patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 185551 question first answered 05/11/2018 15:27:30 answering member 4067 label Biography information for Steve Brine
tabling member	1513 label Biography information for Jo Swinson

997641

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 October 2018 to Question 173542 on Allergies: Medical Treatments, what assessment he has made of the effect of the national shortage of EpiPen 0.3mg Auto-Injectors on levels of supply of alternative epinephrine auto-injectors.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	185551
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Health products Regulatory Agency, and NHS England to improve the situation as quickly as possible. Supplies of EpiPen 0.3mg and the alternative adrenaline auto-injectors are currently available in volumes that are sufficient to meet normal United Kingdom requirements and further deliveries of all three brands of adrenaline autoinjectors are expected in the coming weeks. Comprehensive information and guidance, with input from National Health Service allergy experts has been cascaded to all healthcare professionals, schools, patient groups and frontline NHS services, which provides information about the supply issue, management options and advice to share with patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 185550 question first answered 05/11/2018 15:27:30 answering member 4067 label Biography information for Steve Brine
tabling member	1513 label Biography information for Jo Swinson

997660

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Special Educational Needs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department allocated from the public purse to (a) NHS Learning Support Fund payments, (b) NHS Learning Support Fund Travel and Dual Accommodation Expenses payments, (c) NHS Learning Support Fund Child Dependants Allowance payments and (d) NHS Learning Support Fund Exceptional Support Fund payments for the period 1 September 2017 to 31 August 2018.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	185626
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>The Learning Support Fund (LSF) is a demand-led budget with expenditure directly linked to the number of students who receive payment and how much each student receives. The following table shows expenditure on the LSF for the 2017/18 academic year. Academic years are not the same as the financial year. Departmental budgets are set on a financial year basis. The 2017/18 academic year comprises part of the 2017/18 and 2018/19 financial years. Work is on-going with the university sector to ensure they continue to highlight the availability of the additional non-repayable funding that is available in England to Nursing, Midwifery and Allied Health Professional undergraduate students during their study.</p><p> </p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>1 September 2017 to 31 August 2018</p></td></tr><tr><td><p>LSF Element</p></td><td><p>£ million</p></td><td><p>Number of Approved Applications</p></td></tr><tr><td><p>Travel and Dual Accommodation Expenses</p></td><td><p>£1.7</p></td><td><p>7,422</p></td></tr><tr><td><p>Child Dependants Allowance</p></td><td><p>£3.7</p></td><td><p>4,305</p></td></tr><tr><td><p>Exceptional Support Fund</p></td><td><p>£0.1</p></td><td><p>214</p></td></tr><tr><td><p>Total</p></td><td><p>£5.5</p></td><td><p>11,941</p></td></tr></tbody></table><p>Source: NHS Business Services Authority</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 06/11/2018 11:05:52 answering member 4095 label Biography information for Steve Barclay
tabling member	4418 label Biography information for Justin Madders

997662

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Property and Estates Review
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department's response to the Naylor Review of NHS estate published on 30 January 2018, how the £10 billion required will be raised; and how much of that funding will be provided through (a) private finance deals and (b) PF2 projects.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	185593
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The Government has considered its position on the Private Finance Initiative (PFI) and its successor PF2, in light of experience since 2012, and found the model to be inflexible and overly complex. As such, PF2 will no longer be used for any future Government project. However, the Government remains committed to the use of public-private partnership where it delivers value for the taxpayer and fairly transfers risk to the private sector.</p><p> </p><p>The Government has committed to consider proposals from the National Health Service for a multi-year capital plan to support transformation, as part of the long-term plan the NHS is currently developing. Future years capital funding will be set as part of the Spending Review next year.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 05/11/2018 15:54:09 answering member 4095 label Biography information for Steve Barclay
tabling member	4088 label Biography information for Stella Creasy

997684

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of supply of the flu vaccine for (a) people aged over 65 and (b) in general in (i) England and (ii) Gloucestershire; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	185488
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Providers are responsible for ordering flu vaccines for adults. This winter those aged 65 and over are being offered a newly licenced adjuvanted trivalvent influenza vaccine, Fluad which is intended to offer better protection to this age group. Manufacturer deliveries are being staggered from September to November which may result in some temporary local shortages. A quadrivalent influenza vaccine is recommended for adults aged 18 to 64. There currently remains a surplus of vaccine available to be ordered from manufacturers at a national level. We do not hold specific information on Gloucestershire.</p><p> </p><p>For children, Public Health England procures the vaccine centrally with eligible children. Stocks are carefully managed to ensure there is sufficient and equitable distribution across England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/11/2018 15:35:48 answering member 4067 label Biography information for Steve Brine
tabling member	253 label Biography information for Mr Laurence Robertson

997711

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the maternal six-week check is included in the GP contract when such contracts are negotiated.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	185610
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The inclusion of a requirement to carry out the six-week maternal postnatal check for all mothers in the general medical services contract would need to be negotiated and agreed, as part of the annual contract negotiations. We have asked for this issue to be considered in the contract negotiations for 2019/20. The details of those negotiations are not generally discussed until an agreement on the way forward has been reached.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/11/2018 11:09:13 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

997715

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to provide increased funding for research into congenital heart defects in babies.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	185611
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including congenital heart defects in babies. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p><p> </p><p>The NIHR continues to fund and support a range of research into congenital heart defects in babies, including the following projects:</p><p>- MRI-augmented guidance for X-ray fluoroscopic paediatric cardiovascular interventions (£415,000);</p><p>- Mixed Reality Imaging of Congenital Heart Disease to Improve Surgical Decision-Making (£453,000); and</p><p>- Infant deaths in the United Kingdom community following successful cardiac surgery - building the evidence base for optimal surveillance (£22.800).</p><p>Information on individual projects funded by the NIHR can be found at the following link:</p><p> </p><p><strong><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/11/2018 16:43:16 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4243 label Biography information for Dan Jarvis